Active ingredientBetaxololCat. No. P-B065-001CAS 63659-18-7Family · Pharmaceutical analytical standards
Betaxolol
A beta-blocker selective for the heart's beta-1 receptors, patented in 1975 and approved in 1983: by mouth it treats high blood pressure, as eye drops it lowers eye pressure in glaucoma. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?The ending '-olol' comes from the name of propranolol, the first widely used beta-blocker, and is shared by many beta-blockers: it lets the drug's class be recognised at a glance.
Go to the active ingredient →Active ingredientBetaxololCat. No. P-B065-001CAS 63659-18-7
Active ingredientBetaxolol HydrochlorideCat. No. P-B065-002CAS 63659-19-8
Pharmacopoeial impurityBetaxolol EP Impurity ACat. No. P-B065-003CAS 67193-95-7
Pharmacopoeial impurityBetaxolol EP Impurity CCat. No. P-B065-004CAS 63659-17-6
Pharmacopoeial impurityBetaxolol EP Impurity A HClCat. No. P-B065-005CAS 464877-45-0
Pharmacopoeial impurityBetaxolol EP Impurity DCat. No. P-B065-006CAS 63659-16-5
Pharmacopoeial impurityBetaxolol EP Impurity ECat. No. P-B065-007CAS 1329613-85-5
Pharmacopoeial impurityBetaxolol EP Impurity E HClCat. No. P-B065-008CAS 2724726-61-6
Isotopically labelledBetaxolol-d5 HydrochlorideCat. No. P-B065-010CAS 1189957-99-0
Isotopically labelledBetaxolol-d7 HClCat. No. P-B065-011CAS 1219802-92-2
NitrosamineN-Nitroso-BetaxololCat. No. P-B065-012
ImpurityAlpha-HydroxybetaxololCat. No. P-B065-013CAS 87549-35-7
ImpurityBetaxolol Impurity 1Cat. No. P-B065-015CAS 2490668-09-0
ImpurityLevobetaxolol HydrochlorideCat. No. P-B065-022CAS 116209-55-3No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Reference substanceBetaxolol hydrochloride CRSEDQM code B1103000Family BetaxololImpurityBetaxolol impurity A CRSEDQM code B1103100Family BetaxololImpurityBetaxolol impurity C CRSEDQM code Y0001354Family BetaxololNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.